Phase 2 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with prostate cancer through a tissue biopsy, and whose treatment plan includes a type of internal radiation therapy (called HDR brachytherapy) combined with external beam radiotherapy aimed at curing the cancer.
- People who are either fully active or have only minor limitations in daily physical activity (this is measured using a standard medical scale called ECOG, scored 0 or 1).
- People who have few or no serious other health conditions, based on a standard health scoring system called the Charlson Comorbidity Index, with a score of 4 or below.
- People whose cancer, as seen on imaging scans, covers less than half of the prostate gland and matches what was found in the biopsy results.
Who may not be able to join:
- No specific exclusion criteria have been listed for this trial (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 514-890-8254
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Urinary Quality of Life
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.